InvestorsHub Logo

biosectinvestor

12/01/21 10:44 PM

#423227 RE: Doc logic #423218

I canMt speak to the process timing or the specifics of what anyone might pursue, and I think flipper is talking of the U.K. procedures frequently, which is not an area in which I have deeply delved. I think manufacturing capability at their own, scalable facility, will be an important and major step forward. I do not see how anyone claiming this failed can suggest or justify that the UK would be allowing the manufacture and sale of such a product to the public, at full, out of pocket cost.

The thing they claim is exactly what these regulators exist to stop, that is why they were created, to stomp snake oil sales, which is what they are arguing is the current situation with DCVax-L. It seems to me, JIMHO, obviously ludicrous.

MI Dendream

12/01/21 11:20 PM

#423233 RE: Doc logic #423218

In my experience FDA can and does share draft guidance with some or all and let them start to live by that guidance before it becomes official. It is kind of like a beta test.

If the guidance is changing, they may have communicated the new guidance to NWBO and allowed them to begin the process and by sharing the guidance has all but assured them of the success of their new approach. In fact, they have been known to tell you their true target approval date which is not a guarantee but is a very real goal and much earlier than the PDUFA date. Companies need to prepare for an approval and they need cash to do it. You have materials to print, websites to build, phone lines to activate, and supplies to purchase. They understand this and work with you, not against you. If it is coming down to PDUFA and you don’t know what they will do, that is not a good sign at all. Not necessarily the death nail, but not a bed of roses either.

Oh yea, you also have contracts to execute and manufacturing suites to secure and staff to hire…

I don’t know, maybe you need an extra 15 million to get’er done and be ready.